We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$79.9B
AUM Growth
+$16.7B
Cap. Flow
+$9.74B
Cap. Flow %
12.19%
Top 10 Hldgs %
13.34%
Holding
4,935
New
829
Increased
1,631
Reduced
1,587
Closed
796

Sector Composition

Rank Sector Weight
1 Healthcare 10.45%
2 Technology 8.65%
3 Financials 8.6%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
4126
PUT
American International
AIG
$40.5B
-6,700
Closed -$373K
AIRG icon
4127
Airgain
AIRG
$68.4M
-10,938
Closed -$128K
AKRO
4128
DELISTED
Akero Therapeutics
AKRO
-73,621
Closed -$1.67M
AL
4129
DELISTED
Air Lease Corp
AL
-7,540
Closed -$315K
CHGA
4130
Change Agents Corp
CHGA
$3.48M
-269
Closed -$75K
ALC icon
4131
Alcon
ALC
$35.6B
-218,445
Closed -$12.5M
ALKS icon
4132
CALL
Alkermes
ALKS
$8.2B
-150,000
Closed -$2.93M
ALLO icon
4133
CALL
Allogene Therapeutics
ALLO
$701M
-100,000
Closed -$2.73M
ALRS icon
4134
Alerus Financial
ALRS
$818M
-9,198
Closed -$200K
AMBA icon
4135
Ambarella
AMBA
$3.07B
-327,253
Closed -$20.6M
AMCX icon
4136
AMC Global Media
AMCX
$512M
-35,859
Closed -$1.76M
AMCR icon
4137
Amcor
AMCR
$22.2B
-677,469
Closed -$33M
AMP icon
4138
PUT
Ameriprise Financial
AMP
$49.6B
-60,000
Closed -$8.83M
AMPH icon
4139
Amphastar Pharmaceuticals
AMPH
$915M
-54,180
Closed -$1.07M
AMPY icon
4140
Amplify Energy
AMPY
$198M
-19,848
Closed -$122K
AMSC icon
4141
American Superconductor
AMSC
$1.4B
-13,376
Closed -$104K
AMTB icon
4142
Amerant Bancorp
AMTB
$1.13B
-11,771
Closed -$246K
ANGO icon
4143
AngioDynamics
ANGO
$652M
-64,952
Closed -$992K
AORT icon
4144
Artivion
AORT
$1.31B
-16,633
Closed -$451K
AOSL icon
4145
Alpha and Omega Semiconductor
AOSL
$783M
-13,924
Closed -$170K
APLT
4146
DELISTED
Applied Therapeutics
APLT
-26,290
Closed -$288K
AQMS icon
4147
Aqua Metals
AQMS
$9.95M
-96
Closed -$32K
ARDC
4148
Are Dynamic Credit Allocation Fund
ARDC
$294M
-13,359
Closed -$199K
ARDX icon
4149
Ardelyx
ARDX
$966M
-25,103
Closed -$117K
AROW icon
4150
Arrow Financial
AROW
$710M
-15,844
Closed -$470K

Similar funds

Israel Englander's Q4 2019 Portfolio in Review

As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.

  • Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
  • Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
  • Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
  • Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
  • Israel Englander opened 829 new positions and closed 796 in Q4 2019.
  • Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.